Phosphodiesterase type 5 inhibitors after left ventricular assist device: no free lunch?
ESC Heart Fail
.
2021 Aug;8(4):2365-2367.
doi: 10.1002/ehf2.13393.
Epub 2021 May 10.
Authors
E Wilson Grandin
1
,
Jeffrey J Teuteberg
2
Affiliations
1
Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
2
Cardiovascular Medicine, Stanford University, Stanford, CA, USA.
PMID:
33969639
PMCID:
PMC8318508
DOI:
10.1002/ehf2.13393
No abstract available
Publication types
Editorial
Comment
MeSH terms
Heart Failure* / therapy
Heart-Assist Devices*
Humans
Phosphodiesterase 5 Inhibitors
Ventricular Dysfunction, Right*
Substances
Phosphodiesterase 5 Inhibitors